Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood|October 21, 2006
Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemiaDavid Cervi, Yuval Shaked, Mehran Haeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Dose-dependent increases in circulating TGF-alpha and other EGFR ligands act as pharmacodynamic markers for optimal biological dosing of cetuximab and are tumor independentAnthony J Mutsaers, Giulio Francia, Shan Man, et al.
Molecular Cancer Therapeutics|October 15, 2008
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell linesGiulio Francia, Urban Emmenegger, Christina R Lee, et al.
Cancer Research|September 22, 2016
Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal CancersFlorence T H Wu, Shan Man, Ping Xu, et al.
Cancer Research|January 18, 2008
Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growthJohn M L Ebos, Christina R Lee, Elena Bogdanovic, et al.
Science (New York, N.Y.)|September 23, 2006
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumorsYuval Shaked, Alessia Ciarrocchi, Marcela Franco, et al.
EMBO Molecular Medicine|November 2, 2014
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacyJohn M L Ebos, Michalis Mastri, Christina R Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2023
Recent Thymic Emigrants Require RBPJ-Dependent Notch Signaling to Transition into Functionally Mature Naive T CellsSintia Teichman, Helen Wang, Christina R Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancerElizabeth Pham, Michael J Birrer, Scott Eliasof, et al.
Leukemia Research|May 14, 2014
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesisRena Buckstein, Robert Kerbel, Matthew Cheung, et al.
Pageof 4